Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYMerus N.V. Announces Proposed Underwritten Public Offering of Common SharesPREV STORYRhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019